Allegro’s osteoarthritis hydrogel reduces lameness in animal study
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 12 […]
Author: Douwe Miedema
Allegro to start production of osteoarthritis hydrogel device as it prepares for clinical trials
Liege, Belgium – 9 January 2026 (08:30 CET) – Allegro NV, a biomedical company developing transformative injectable, mechanically-acting devices for osteoarthritis, will […]